Producing an active return (𝝰)
SymphonyAlpha is a venture capital firm with a primary focus on early-stage healthcare IT companies. The fund targets promising healthcare technology start-ups with a strong entrepreneurial team, a compelling value proposition, and potential for recurring SaaS revenues. The fund is led by seasoned entrepreneurs including Ravi Kalla, an entrepreneur with significant success in building healthcare IT companies. The team takes a hands-on approach with each portfolio company by helping facilitate connections to prospective clients, access to industry subject matter experts, accelerated solution development, business model development, and strategic vision.
SymphonyAlpha leverages its parent company, Symphony Corporation, which boasts strengths in accelerated development and commercialization processes. SymphonyAlpha and its affiliates bring proven experience in building successful healthcare companies from concept to commercially viable products in a short timeframe by leveraging its innovation partnerships with well-known healthcare systems.
Accelerated Market Penetration
Our success primarily stems from our ability to help entrepreneurs bring commercially viable solutions to the market faster. In the new fast-evolving Healthcare IT market, early-stage companies benefit from a time-to-market advantage and revenue-generating pilot partners to be successful. We collaborate with portfolio company management teams to bring the right pieces together by leveraging our strengths to increase your odds of success. Start-ups, like anything else, are easier said than done, but we have the results to prove our model.
Strategic Value to Portfolio Companies
- Business model refinement through collaborative work with health systems and other innovation partners
- Connection to the right prospective clients within our network
- Help in building scalable solutions with an accelerate timeline
- Subject matter experts to enhance the solution ensure product-market fit over time
- Introduction to prospective prospective board members, senior managers, and other investors
WHAT WE INVEST IN
HOW WE INVEST
SymphonyAlpha will invest capital in promising start-ups that are in their early stages but have a minimum viable product (MVP) that they are looking to improve as they build market insight and start to demonstrate product-market fit.
For a start-up in pre-MVP and post-MVP stage, SymphonyAlpha, through Symphony Corporation, a global IT consulting firm, can serve as a provider of development services. Symphony offers a 360° partnership approach and serves its clients from concept to full-cycle product development, deployment and support. Symphony brings extensive experience, mature product development processes and technology frameworks for new product development. The combination of our domain expertise with matured quality management systems and proven skills in state of the art technologies offer key advantages—faster, better and more cost-effective solutions for start-up clients.
SymphonyAlpha, also through Symphony Corporation, can provide product development services as part of an equity partnership with companies that bring compelling opportunities to the table but still need significant investments in R&D throughout the pre-seed stage.
Symphony developed the SymphonyCare technology platform as a comprehensive population analytics and clinical workflow tool to help healthcare providers and payers adapt to evolving delivery requirements. Influence Health acquired the Symphony-built technology to add powerful clinical and financial capabilities to their market-leading patient engagement offering.
SymphonyCare was re-launched in 2017. Learn more ↗
Acquired by MD Revolution in November, 2019.
Symphony developed the initial product for Liazon Corporation, an online private benefits exchange solution, as an early-stage development partner. By developing this Minimum Viable Product (MVP), Symphony helped enable a large private equity round and an ultimate acquisition by Towers Watson for $215 million in November of 2013.
Symphony Data Corporation
Symphony Data Corporation was perhaps the most successful SymphonyAlpha spin-off to date. Its Business Process Outsourcing business grew quickly and attracted a strategic buyer in Zavata in 2005. Two years after this nine-figure exit, Zavata was then acquired by Apollo Health Street.
22 E Mifflin Street
Madison, WI 53703
+ 1 608 294 4090